ID   MRC-5 PDL12
AC   CVCL_JF54
SY   MRC-5 PDL 12; WHO MRC-5 660902-M01
DR   Wikidata; Q54906585
RX   CelloPub=CLPUB00783;
RX   CelloPub=CLPUB00784;
WW   Provider; WHO; -; https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/norms-and-standards/who-reference-cell-banks
CC   Group: Vaccine production cell line.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 8
CH   CVCL_E5ZR ! MRC-5 PDL13
//
RX   CelloPub=CLPUB00783;
RA   Stacey, Glyn N.
RA   Hawkins, J. Ross
RA   Carter, Penny
RA   Hunt, Charles John
RA   Young, Lesley A.
RT   "Replacement seed stock for MRC-5 cells.";
RL   (In technical document) World Health Organization publication WHO/BS/07.2077; pp.1-9; WHO; Geneva; Switzerland (2007).
//
RX   CelloPub=CLPUB00784;
RA   Hawkins, J. Ross
RA   Stylianou, Miltiades
RT   "Second replacement seed stock for MRC-5 cells. Proposal for WHO
RT   reference cell bank status.";
RL   (In technical document) World Health Organization publication WHO/BS/2018.2347; pp.1-7; WHO; Geneva; Switzerland (2018).
//